Diag Capital Management »

Biohaven Pharmaceutical Holding shares owned by Diag Capital Management

Quarter-by-quarter ownership of Biohaven Pharmaceutical Holding shares owned by Diag Capital Management from 13F filings

Historical chart of Diag Capital Management investment in Biohaven Pharmaceutical Holding

Tip: Access up to 7 years of quarterly data

All positions including Biohaven Pharmaceutical Holding held by Diag Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven Pharmaceutical Holding by Diag Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $1.4M 38k 36.98

More positions owned by Diag Capital Management

Baxter International (BAX)
Athenex
Zimmer Holdings (ZBH)
Abbvie (ABBV)
Incyte Corporation (INCY)
Quanterix Ord (QTRX)
Celgene Corporation
Amgen (AMGN)
Foamix Pharmaceuticals
Medtronic (MDT)
Quotient
Pacira Pharmaceuticals conv
Takeda Pharmaceutical (TAK)
Abbott Laboratories (ABT)
Zai Lab (ZLAB)

View all positions for Diag Capital Management

Top funds holding Biohaven Pharmaceutical Holding

Knoll Capital Management

View all funds holding Biohaven Pharmaceutical Holding